ASX Announcement 19 November 2026 BCAL position on GSS-MAP merger Highlights • BCAL prepared to support GSS-MAP merger on appropriate terms and support an expedited process, in the absence of a superior proposal for GSS • BCAL to consider providing funding to MAP for working capital to enable...
BCAL Position on GSS-MAP Merger
Filed with ASX · · 2 pages · English
Release
BCAL Diagnostics Limited on 6ix
Story so far
Earlier from BCAL Diagnostics
- Notification regarding unquoted securities - BDX
- Change of Director's Interest Notice
- BCAL Expands Breast Cancer Biomarker Program
- Notification of cessation of securities - BDX
- Application for quotation of securities - BDX
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics